Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Amneal Reports First Quarter 2024 Financial Results
06:00am, Friday, 03'rd May 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS.
California teams with Amneal Pharma for cheaper, generic version of Narcan
10:48pm, Monday, 29'th Apr 2024
SACRAMENTO, Calif. — California will soon begin selling its own generic version of Narcan — the drug that can save someone's life during an opioid overdose — under a deal announced Monday by Dem
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
06:51am, Thursday, 25'th Apr 2024
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
08:00am, Tuesday, 16'th Apr 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine.
Amneal to Report First Quarter 2024 Results on May 3, 2024
08:00am, Wednesday, 10'th Apr 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal to Report First Quarter 2024 Results on May 3, 2024.
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
04:05pm, Thursday, 28'th Mar 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal to Ring the Nasdaq Closing Bell on April 2, 2024.
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
04:05pm, Monday, 25'th Mar 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension.
Amneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?
07:16am, Wednesday, 20'th Mar 2024
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript
12:26pm, Friday, 01'st Mar 2024
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript
Amneal (AMRX) Reports Q4 Earnings: What Key Metrics Have to Say
10:31am, Friday, 01'st Mar 2024
The headline numbers for Amneal (AMRX) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings Estimates
08:16am, Friday, 01'st Mar 2024
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.23 per share a year ago.
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
06:00am, Friday, 01'st Mar 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the fourth quarter and full year ended December 31,
Countdown to Amneal (AMRX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
10:16am, Tuesday, 27'th Feb 2024
Beyond analysts' top -and-bottom-line estimates for Amneal (AMRX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
Amneal (AMRX) Shows Fast-paced Momentum But Is Still a Bargain Stock
09:51am, Wednesday, 21'st Feb 2024
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Amneal (AMRX) could be a great choice. It is one of the several stocks that passed t
Amneal to Participate at Upcoming Investor Conference
08:00am, Tuesday, 13'th Feb 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer, will participate in the following investor conference. Ba
